tiprankstipranks
Therma Bright’s Tech Eyed for Cough Drug Trial
Company Announcements

Therma Bright’s Tech Eyed for Cough Drug Trial

Story Highlights

Therma Bright (TSE:THRM) has released an update.

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

Therma Bright Inc. is gaining attention with its AI-Powered Digital Cough Technology, which is currently being considered for use in a U.S. clinical trial for a new chronic cough drug. The company is also working towards FDA classification and potential CMS reimbursement for the technology, aiming to enhance clinical decision-making and respiratory health monitoring.

For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App